RANDY BANKS: Open Payments
NPI 1144248824 · GULF BREEZE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,091 in 53 payments from 12 companies in 2025. Trend: 2023 $231 · 2024 $797 · 2025 $1,091
Food & beverage: $1,091
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $284 |
| Regeneron Healthcare Solutions, Inc. | 7 | $172 |
| Janssen Biotech, Inc. | 8 | $149 |
| GENZYME CORPORATION | 4 | $107 |
| Galderma Laboratories, L.P. | 5 | $100 |
| Novartis Pharmaceuticals Corporation | 4 | $79 |
| Lilly USA, LLC | 3 | $74 |
| Organogenesis Inc. | 2 | $45 |
| UCB, Inc. | 1 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: DUPIXENT, RINVOQ, TREMFYA, SKYRIZI, NEMLUVIO, EBGLYSS, COSENTYX, Bimzelx.
Industry payments across FL — which companies pay providers there.
